Skip to main content

Halozyme Therapeutic (NQ: HALO )

40.68 -0.05 (-0.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
May 15, 2013
Form 4
Source: SEC/Edgar
May 15, 2013
Form 3
Source: SEC/Edgar
March 27, 2013
Form 4
Source: SEC/Edgar
March 27, 2013
Form 4
Source: SEC/Edgar
February 05, 2013
Form 4
Source: SEC/Edgar
February 05, 2013
Form 4
Source: SEC/Edgar
February 05, 2013
Form 4
Source: SEC/Edgar
February 05, 2013
Form 4
Source: SEC/Edgar
February 05, 2013
Form 4
Source: SEC/Edgar
February 04, 2013
Form 4
Source: SEC/Edgar
February 04, 2013
Form 4
Source: SEC/Edgar
February 04, 2013
Form 4
Source: SEC/Edgar
February 04, 2013
Form 4
Source: SEC/Edgar
February 04, 2013
Form 4
Source: SEC/Edgar
November 28, 2012
Form 4
Source: SEC/Edgar
November 13, 2012
Form 4
Source: SEC/Edgar
November 13, 2012
Form 4
Source: SEC/Edgar
August 27, 2012
Form 4
Source: SEC/Edgar
August 13, 2012
Form 4
Source: SEC/Edgar
June 04, 2012
Form 4
Source: SEC/Edgar
May 16, 2012
Form 4
Source: SEC/Edgar
May 16, 2012
Form 4
Source: SEC/Edgar
May 16, 2012
Form 4
Source: SEC/Edgar
May 16, 2012
Form 4
Source: SEC/Edgar
May 15, 2012
Form 4
Source: SEC/Edgar
May 06, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.